Headlands Technologies »

Enanta Pharmaceuticals shares owned by Headlands Technologies

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2024-09-30 $14k 1.3k 10.36
2024-03-31 $18k 1.1k 17.46

More positions owned by Headlands Technologies

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Palantir Technologies Cl A (PLTR)
Eli Lilly & Co. (LLY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Asml Holding N V N Y Registry Shs (ASML)
Coinbase Global Com Cl A (COIN)
Bank of America Corporation (BAC)
Comcast Corp Cl A (CMCSA)

View all positions for Headlands Technologies

Top funds holding Enanta Pharmaceuticals

Farallon Capital Management
Vanguard Group
BlackRock
BlackRock
Krensavage Asset Management
Morgan Stanley
Armistice Capital
Marshall Wace
Acadian Asset Management
Soleus Capital Management
Bank of America Corporation
Citadel Advisors
Northern Trust
Renaissance Technologies
D. E. Shaw & Co

View all funds holding Enanta Pharmaceuticals